跳至主要内容
临床试验/JPRN-UMIN000018164
JPRN-UMIN000018164已完成未知

Comparison of non-bismuth concomitant and standard triple therapies as a first-line treatment option for Helicobacter pylori in Japan - Concomitant therapies for Helicobacter pylori first line eradication

Tokai University School of Medicine0 个研究点目标入组 220 人开始时间: 2015年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients were excluded from the study if they were younger than 20 years or older than 80 years, were allergic to the drugs used in this therapy. Patients who are disqualified for the study by physicians.

研究者

相似试验